APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Skin Topical Medications

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Skin Topical Medications Market Outlook and Growth Opportunities 2026

Report ID 174036080427 December 2025191 pages

Choose your research edition.

Industry ResearchSkin Topical Medications Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Skin Topical Medications Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Skin Topical Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Skin Topical Medications Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Skin Topical Medications Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Skin Topical Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Skin Topical Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Skin Topical Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Skin Topical Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Skin Topical Medications market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Skin Topical Medications market include Regeneron, Shanghai Xiao Fang Pharmaceutical, Teva, Sandoz, Mylan, Pfizer, Novartis, LEO Pharma and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Skin Topical Medications market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Skin Topical Medications and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Skin Topical Medications revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Skin Topical Medications market.

Skin Topical Medications Segment by Company

Regeneron

Shanghai Xiao Fang Pharmaceutical

Teva

Sandoz

Mylan

Pfizer

Novartis

LEO Pharma

Johnson & Johnson

GlaxoSmithKline

Galderma

Celgene

Allergan

AbbVie

Skin Topical Medications Segment by Type

Antibacterial Agent

Antifungal Agent

Emollient

Others

Skin Topical Medications Segment by Application

For Youth

For the Elderly

For Children

Skin Topical Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Skin Topical Medications status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Skin Topical Medications key companies, revenue, market share, and recent developments.

3. To split the Skin Topical Medications breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Skin Topical Medications market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Skin Topical Medications significant trends, drivers, influence factors in global and regions.

6. To analyze Skin Topical Medications competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Topical Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Skin Topical Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Topical Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Skin Topical Medications industry.

Chapter 3: Detailed analysis of Skin Topical Medications company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Skin Topical Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Skin Topical Medications in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Skin Topical Medications Industry Trends Table 2. Skin Topical Medications Industry Drivers Table 3. Skin Topical Medications Industry Opportunities and Challenges Table 4. Skin Topical Medications Industry Restraints Table 5. Global Skin Topical Medications Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Skin Topical Medications Revenue Share by Company (2021-2026) Table 7. Global Skin Topical Medications Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Skin Topical Medications Key Company Manufacturing Base & Headquarters Table 9. Global Skin Topical Medications Company, Product Type & Application Table 10. Global Skin Topical Medications Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Skin Topical Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Antibacterial Agent Table 15. Significant Companies of Antifungal Agent Table 16. Significant Companies of Emollient Table 17. Significant Companies of Others Table 18. Global Skin Topical Medications Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Skin Topical Medications Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Skin Topical Medications Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Skin Topical Medications Sales Value Share by Type (2021-2026) Table 22. Global Skin Topical Medications Sales Value Share by Type (2027-2032) Table 23. Significant Companies of For Youth Table 24. Significant Companies of For the Elderly Table 25. Significant Companies of For Children Table 26. Global Skin Topical Medications Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Skin Topical Medications Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Skin Topical Medications Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Skin Topical Medications Sales Value Share by Application (2021-2026) Table 30. Global Skin Topical Medications Sales Value Share by Application (2027-2032) Table 31. Global Skin Topical Medications Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Skin Topical Medications Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Skin Topical Medications Sales Value Share by Region (2021-2026) Table 34. Global Skin Topical Medications Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Skin Topical Medications Sales Value Share by Region (2027-2032) Table 36. Global Skin Topical Medications Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Skin Topical Medications Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Skin Topical Medications Sales Value Market Share by Country (2021-2026) Table 39. Global Skin Topical Medications Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Skin Topical Medications Sales Value Market Share by Country (2027-2032) Table 41. Regeneron Company Information Table 42. Regeneron Business Overview Table 43. Regeneron Skin Topical Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Regeneron Skin Topical Medications Product Portfolio Table 45. Regeneron Recent Development Table 46. Shanghai Xiao Fang Pharmaceutical Company Information Table 47. Shanghai Xiao Fang Pharmaceutical Business Overview Table 48. Shanghai Xiao Fang Pharmaceutical Skin Topical Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Shanghai Xiao Fang Pharmaceutical Skin Topical Medications Product Portfolio Table 50. Shanghai Xiao Fang Pharmaceutical Recent Development Table 51. Teva Company Information Table 52. Teva Business Overview Table 53. Teva Skin Topical Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Teva Skin Topical Medications Product Portfolio Table 55. Teva Recent Development Table 56. Sandoz Company Information Table 57. Sandoz Business Overview Table 58. Sandoz Skin Topical Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Sandoz Skin Topical Medications Product Portfolio Table 60. Sandoz Recent Development Table 61. Mylan Company Information Table 62. Mylan Business Overview Table 63. Mylan Skin Topical Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Mylan Skin Topical Medications Product Portfolio Table 65. Mylan Recent Development Table 66. Pfizer Company Information Table 67. Pfizer Business Overview Table 68. Pfizer Skin Topical Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Pfizer Skin Topical Medications Product Portfolio Table 70. Pfizer Recent Development Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Skin Topical Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Novartis Skin Topical Medications Product Portfolio Table 75. Novartis Recent Development Table 76. LEO Pharma Company Information Table 77. LEO Pharma Business Overview Table 78. LEO Pharma Skin Topical Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. LEO Pharma Skin Topical Medications Product Portfolio Table 80. LEO Pharma Recent Development Table 81. Johnson & Johnson Company Information Table 82. Johnson & Johnson Business Overview Table 83. Johnson & Johnson Skin Topical Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Johnson & Johnson Skin Topical Medications Product Portfolio Table 85. Johnson & Johnson Recent Development Table 86. GlaxoSmithKline Company Information Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline Skin Topical Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline Skin Topical Medications Product Portfolio Table 90. GlaxoSmithKline Recent Development Table 91. Galderma Company Information Table 92. Galderma Business Overview Table 93. Galderma Skin Topical Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Galderma Skin Topical Medications Product Portfolio Table 95. Galderma Recent Development Table 96. Celgene Company Information Table 97. Celgene Business Overview Table 98. Celgene Skin Topical Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Celgene Skin Topical Medications Product Portfolio Table 100. Celgene Recent Development Table 101. Allergan Company Information Table 102. Allergan Business Overview Table 103. Allergan Skin Topical Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Allergan Skin Topical Medications Product Portfolio Table 105. Allergan Recent Development Table 106. AbbVie Company Information Table 107. AbbVie Business Overview Table 108. AbbVie Skin Topical Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. AbbVie Skin Topical Medications Product Portfolio Table 110. AbbVie Recent Development Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Skin Topical Medications Product Image Figure 2. Global Skin Topical Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Skin Topical Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Skin Topical Medications Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Antibacterial Agent Image Figure 8. Antifungal Agent Image Figure 9. Emollient Image Figure 10. Others Image Figure 11. Global Skin Topical Medications Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Skin Topical Medications Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Skin Topical Medications Sales Value Share by Type (2021-2032) Figure 14. For Youth Image Figure 15. For the Elderly Image Figure 16. For Children Image Figure 17. Global Skin Topical Medications Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Skin Topical Medications Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Skin Topical Medications Sales Value Share by Application (2021-2032) Figure 20. Global Skin Topical Medications Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Skin Topical Medications Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Skin Topical Medications Sales Value (2021-2032) & (US$ Million) Figure 23. North America Skin Topical Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Skin Topical Medications Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Skin Topical Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Skin Topical Medications Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Skin Topical Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Skin Topical Medications Sales Value (2021-2032) & (US$ Million) Figure 29. South America Skin Topical Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Skin Topical Medications Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Skin Topical Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Skin Topical Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Skin Topical Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Skin Topical Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Antibacterial Agent
  • Antifungal Agent
  • Emollient
  • Others
Applications
  • For Youth
  • For the Elderly
  • For Children
Companies covered
  • Regeneron
  • Shanghai Xiao Fang Pharmaceutical
  • Teva
  • Sandoz
  • Mylan
  • Pfizer
  • Novartis
  • LEO Pharma
  • Johnson & Johnson
  • GlaxoSmithKline
  • Galderma
  • Celgene
  • Allergan
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Skin Topical Medications Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Skin Topical Medications Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Skin Topical Medications Market Dynamics
  1. 2.1 Skin Topical Medications Industry Trends
  2. 2.2 Skin Topical Medications Industry Drivers
  3. 2.3 Skin Topical Medications Industry Opportunities and Challenges
  4. 2.4 Skin Topical Medications Industry Restraints
3 Skin Topical Medications Market by Company
  1. 3.1 Global Skin Topical Medications Company Revenue Ranking in 2025
  2. 3.2 Global Skin Topical Medications Revenue by Company (2021-2026)
  3. 3.3 Global Skin Topical Medications Company Ranking (2024-2026)
  4. 3.4 Global Skin Topical Medications Company Manufacturing Base and Headquarters
  5. 3.5 Global Skin Topical Medications Company Product Type and Application
  6. 3.6 Global Skin Topical Medications Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Skin Topical Medications Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Skin Topical Medications Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Skin Topical Medications Market by Type
  1. 4.1 Skin Topical Medications Type Introduction
  2. 4.1.1 Antibacterial Agent
  3. 4.1.2 Antifungal Agent
  4. 4.1.3 Emollient
  5. 4.1.4 Others
  6. 4.2 Global Skin Topical Medications Sales Value by Type
  7. 4.2.1 Global Skin Topical Medications Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Skin Topical Medications Sales Value by Type (2021-2032)
  9. 4.2.3 Global Skin Topical Medications Sales Value Share by Type (2021-2032)
5 Skin Topical Medications Market by Application
  1. 5.1 Skin Topical Medications Application Introduction
  2. 5.1.1 For Youth
  3. 5.1.2 For the Elderly
  4. 5.1.3 For Children
  5. 5.2 Global Skin Topical Medications Sales Value by Application
  6. 5.2.1 Global Skin Topical Medications Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Skin Topical Medications Sales Value by Application (2021-2032)
  8. 5.2.3 Global Skin Topical Medications Sales Value Share by Application (2021-2032)
6 Skin Topical Medications Regional Value Analysis
  1. 6.1 Global Skin Topical Medications Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Skin Topical Medications Sales Value by Region (2021-2032)
  3. 6.2.1 Global Skin Topical Medications Sales Value by Region: 2021-2026
  4. 6.2.2 Global Skin Topical Medications Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Skin Topical Medications Sales Value (2021-2032)
  7. 6.3.2 North America Skin Topical Medications Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Skin Topical Medications Sales Value (2021-2032)
  10. 6.4.2 Europe Skin Topical Medications Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Skin Topical Medications Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Skin Topical Medications Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Skin Topical Medications Sales Value (2021-2032)
  16. 6.6.2 South America Skin Topical Medications Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Skin Topical Medications Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Skin Topical Medications Sales Value Share by Country, 2025 VS 2032
7 Skin Topical Medications Country-level Value Analysis
  1. 7.1 Global Skin Topical Medications Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Skin Topical Medications Sales Value by Country (2021-2032)
  3. 7.2.1 Global Skin Topical Medications Sales Value by Country (2021-2026)
  4. 7.2.2 Global Skin Topical Medications Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Skin Topical Medications Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Skin Topical Medications Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Skin Topical Medications Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Skin Topical Medications Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Skin Topical Medications Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Skin Topical Medications Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Skin Topical Medications Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Skin Topical Medications Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Skin Topical Medications Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Skin Topical Medications Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Skin Topical Medications Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Skin Topical Medications Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Skin Topical Medications Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Skin Topical Medications Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Skin Topical Medications Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Skin Topical Medications Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Skin Topical Medications Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Skin Topical Medications Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Skin Topical Medications Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Skin Topical Medications Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Skin Topical Medications Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Skin Topical Medications Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Skin Topical Medications Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Skin Topical Medications Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Skin Topical Medications Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Skin Topical Medications Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Skin Topical Medications Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Skin Topical Medications Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Skin Topical Medications Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Skin Topical Medications Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Regeneron
  2. 8.1.1 Regeneron Company Information
  3. 8.1.2 Regeneron Business Overview
  4. 8.1.3 Regeneron Skin Topical Medications Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Regeneron Skin Topical Medications Product Portfolio
  6. 8.1.5 Regeneron Recent Developments
  7. 8.2 Shanghai Xiao Fang Pharmaceutical
  8. 8.2.1 Shanghai Xiao Fang Pharmaceutical Company Information
  9. 8.2.2 Shanghai Xiao Fang Pharmaceutical Business Overview
  10. 8.2.3 Shanghai Xiao Fang Pharmaceutical Skin Topical Medications Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Xiao Fang Pharmaceutical Skin Topical Medications Product Portfolio
  12. 8.2.5 Shanghai Xiao Fang Pharmaceutical Recent Developments
  13. 8.3 Teva
  14. 8.3.1 Teva Company Information
  15. 8.3.2 Teva Business Overview
  16. 8.3.3 Teva Skin Topical Medications Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Skin Topical Medications Product Portfolio
  18. 8.3.5 Teva Recent Developments
  19. 8.4 Sandoz
  20. 8.4.1 Sandoz Company Information
  21. 8.4.2 Sandoz Business Overview
  22. 8.4.3 Sandoz Skin Topical Medications Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sandoz Skin Topical Medications Product Portfolio
  24. 8.4.5 Sandoz Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Skin Topical Medications Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Skin Topical Medications Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Skin Topical Medications Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Skin Topical Medications Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Novartis
  38. 8.7.1 Novartis Company Information
  39. 8.7.2 Novartis Business Overview
  40. 8.7.3 Novartis Skin Topical Medications Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Novartis Skin Topical Medications Product Portfolio
  42. 8.7.5 Novartis Recent Developments
  43. 8.8 LEO Pharma
  44. 8.8.1 LEO Pharma Company Information
  45. 8.8.2 LEO Pharma Business Overview
  46. 8.8.3 LEO Pharma Skin Topical Medications Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LEO Pharma Skin Topical Medications Product Portfolio
  48. 8.8.5 LEO Pharma Recent Developments
  49. 8.9 Johnson & Johnson
  50. 8.9.1 Johnson & Johnson Company Information
  51. 8.9.2 Johnson & Johnson Business Overview
  52. 8.9.3 Johnson & Johnson Skin Topical Medications Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Johnson & Johnson Skin Topical Medications Product Portfolio
  54. 8.9.5 Johnson & Johnson Recent Developments
  55. 8.10 GlaxoSmithKline
  56. 8.10.1 GlaxoSmithKline Company Information
  57. 8.10.2 GlaxoSmithKline Business Overview
  58. 8.10.3 GlaxoSmithKline Skin Topical Medications Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GlaxoSmithKline Skin Topical Medications Product Portfolio
  60. 8.10.5 GlaxoSmithKline Recent Developments
  61. 8.11 Galderma
  62. 8.11.1 Galderma Company Information
  63. 8.11.2 Galderma Business Overview
  64. 8.11.3 Galderma Skin Topical Medications Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Galderma Skin Topical Medications Product Portfolio
  66. 8.11.5 Galderma Recent Developments
  67. 8.12 Celgene
  68. 8.12.1 Celgene Company Information
  69. 8.12.2 Celgene Business Overview
  70. 8.12.3 Celgene Skin Topical Medications Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Celgene Skin Topical Medications Product Portfolio
  72. 8.12.5 Celgene Recent Developments
  73. 8.13 Allergan
  74. 8.13.1 Allergan Company Information
  75. 8.13.2 Allergan Business Overview
  76. 8.13.3 Allergan Skin Topical Medications Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Allergan Skin Topical Medications Product Portfolio
  78. 8.13.5 Allergan Recent Developments
  79. 8.14 AbbVie
  80. 8.14.1 AbbVie Company Information
  81. 8.14.2 AbbVie Business Overview
  82. 8.14.3 AbbVie Skin Topical Medications Revenue and Gross Margin (2021-2026)
  83. 8.14.4 AbbVie Skin Topical Medications Product Portfolio
  84. 8.14.5 AbbVie Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst